KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 0.01%.

  • Evolent Health's Return on Capital Employed rose 100.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.02% for FY2024, which is 200.0% up from last year.
  • Per Evolent Health's latest filing, its Return on Capital Employed stood at 0.01% for Q3 2025, which was up 100.0% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Return on Capital Employed peaked at 0.0% during Q4 2022, and registered a low of 0.27% during Q1 2021.
  • In the last 5 years, Evolent Health's Return on Capital Employed had a median value of 0.02% in 2024 and averaged 0.04%.
  • The largest annual percentage gain for Evolent Health's Return on Capital Employed in the last 5 years was 4700bps (2021), contrasted with its biggest fall of -400bps (2021).
  • Over the past 5 years, Evolent Health's Return on Capital Employed (Quarter) stood at 0.05% in 2021, then soared by 106bps to 0.0% in 2022, then tumbled by -1424bps to 0.04% in 2023, then soared by 37bps to 0.02% in 2024, then soared by 55bps to 0.01% in 2025.
  • Its Return on Capital Employed stands at 0.01% for Q3 2025, versus 0.02% for Q2 2025 and 0.02% for Q1 2025.